{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T05:17:41Z","timestamp":1784351861998,"version":"3.55.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T00:00:00Z","timestamp":1667347200000},"content-version":"vor","delay-in-days":32,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010318","name":"Landelijke Stichting voor Blinden en Slechtzienden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010318","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010321","name":"Oogfonds","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010302","name":"Algemene Nederlandse Vereniging ter voorkoming van Blindheid","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010302","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["phiro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physics and Imaging in Radiation Oncology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.phro.2022.11.001","type":"journal-article","created":{"date-parts":[[2022,11,6]],"date-time":"2022-11-06T11:34:31Z","timestamp":1667734471000},"page":"102-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Automatic Three-Dimensional Magnetic Resonance-based measurements of tumour prominence and basal diameter for treatment planning of uveal melanoma"],"prefix":"10.1016","volume":"24","author":[{"given":"Lisa","family":"Klaassen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam G.","family":"Jaarsma-Coes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berit M.","family":"Verbist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.H. Khanh","family":"Vu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Marinkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coen R.N.","family":"Rasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregorius P.M.","family":"Luyten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Willem M.","family":"Beenakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phro.2022.11.001_b0005","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41572-020-0158-0","article-title":"Uveal melanoma","volume":"6","author":"Jager","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.phro.2022.11.001_b0010","doi-asserted-by":"crossref","DOI":"10.1177\/1758834018757175","article-title":"Treatment of uveal melanoma: where are we now?","author":"Yang","year":"2018","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.phro.2022.11.001_b0015","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/eye.2016.275","article-title":"Uveal melanoma: relatively rare but deadly cancer","volume":"31","author":"Kaliki","year":"2017","journal-title":"Eye"},{"key":"10.1016\/j.phro.2022.11.001_b0020","doi-asserted-by":"crossref","first-page":"50","DOI":"10.21037\/cco.2016.07.06","article-title":"Proton therapy for the management of uveal melanoma and other ocular tumors","volume":"5","author":"Mishra","year":"2016","journal-title":"Chin Clin Oncol"},{"key":"10.1016\/j.phro.2022.11.001_b0025","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s00347-017-0560-5","article-title":"CyberKnife(R): new treatment option for uveal melanoma","volume":"115","author":"Mor","year":"2018","journal-title":"Ophthalmologe"},{"key":"10.1016\/j.phro.2022.11.001_b0030","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/S1470-2045(20)30459-9","article-title":"Gamma knife radiosurgery for uveal melanomas and metastases: a systematic review and meta-analysis","volume":"21","author":"Parker","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.phro.2022.11.001_b0035","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ijrobp.2016.01.040","article-title":"Practice patterns analysis of ocular proton therapy centers: The International OPTIC Survey","volume":"95","author":"Hrbacek","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2022.11.001_b0040","doi-asserted-by":"crossref","first-page":"965","DOI":"10.4149\/neo_2018_171209N808","article-title":"Uveal melanoma survival rates after single dose stereotactic radiosurgery","volume":"65","author":"Furdova","year":"2018","journal-title":"Neoplasma"},{"key":"10.1016\/j.phro.2022.11.001_b0045","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1001\/archopht.1985.01050070050028","article-title":"Comparison of uveal melanoma growth rates with mitotic index and mortality","volume":"103","author":"Gass","year":"1985","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.phro.2022.11.001_b0050","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14133147","article-title":"Imaging of uveal melanoma-current standard and methods in development","volume":"14","author":"Solnik","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.phro.2022.11.001_b0055","series-title":"AJCC Cancer Staging Manual","author":"Amin","year":"2017"},{"key":"10.1016\/j.phro.2022.11.001_b0060","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4103\/0301-4738.154367","article-title":"Uveal melanoma: estimating prognosis","volume":"63","author":"Kaliki","year":"2015","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.phro.2022.11.001_b0065","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1136\/bjo.74.3.183","article-title":"Ultrasonographic measurement of uveal melanoma thickness: interobserver variability","volume":"74","author":"Char","year":"1990","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.phro.2022.11.001_b0070","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1136\/bjo.86.12.1390","article-title":"Interobserver and intraobserver variability of measurements of uveal melanomas using standardised echography","volume":"86","author":"Haritoglou","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.phro.2022.11.001_b0075","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s00234-015-1546-0","article-title":"Quantitative multiparametric MRI in uveal melanoma: increased tumor permeability may predict monosomy 3","volume":"57","author":"Kamrava","year":"2015","journal-title":"Neuroradiology"},{"key":"10.1016\/j.phro.2022.11.001_b0080","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00234-021-02825-5","article-title":"MR imaging characteristics of uveal melanoma with histopathological validation","volume":"64","author":"Ferreira","year":"2022","journal-title":"Neuroradiology"},{"key":"10.1016\/j.phro.2022.11.001_b0085","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13244-021-01000-x","article-title":"Diagnostic methods and therapeutic options of uveal melanoma with emphasis on MR imaging-Part I: MR imaging with pathologic correlation and technical considerations","volume":"12","author":"Foti","year":"2021","journal-title":"Insights Imaging"},{"key":"10.1016\/j.phro.2022.11.001_b0090","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1080\/02713683.2021.1874021","article-title":"Ophthalmic magnetic resonance imaging: where are we (heading to)?","volume":"46","author":"Niendorf","year":"2021","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.phro.2022.11.001_b0095","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s10334-016-0529-4","article-title":"Clinical evaluation of ultra-high-field MRI for three-dimensional visualisation of tumour size in uveal melanoma patients, with direct relevance to treatment planning","volume":"29","author":"Beenakker","year":"2016","journal-title":"MAGMA"},{"key":"10.1016\/j.phro.2022.11.001_b0100","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11030377","article-title":"MRI of uveal melanoma","volume":"11","author":"Ferreira","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.phro.2022.11.001_b0105","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00066-006-1512-1","article-title":"Proton therapy of uveal melanomas: intercomparison of MRI-based and conventional treatment planning","volume":"182","author":"Marnitz","year":"2006","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.phro.2022.11.001_b0110","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ciresp.2019.04.017","article-title":"Accuracy of tumor size measurements performed by magnetic resonance, ultrasound and mammography, and their correlation with pathological size in primary breast cancer","volume":"97","author":"Cuesta Cuesta","year":"2019","journal-title":"Cir Esp (Engl Ed)"},{"key":"10.1016\/j.phro.2022.11.001_b0115","doi-asserted-by":"crossref","first-page":"119","DOI":"10.5152\/ejbh.2019.4547","article-title":"Comparison of MRI and US in tumor size evaluation of breast cancer patients receiving neoadjuvant chemotherapy","volume":"15","author":"Taydas","year":"2019","journal-title":"Eur J Breast Health"},{"key":"10.1016\/j.phro.2022.11.001_b0120","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.7863\/ultra.32.10.1703","article-title":"Size discrepancy between sonographic and computed tomographic\/magnetic resonance imaging measurement of hepatocellular carcinoma: the necessity of tumor size measurement standardization","volume":"32","author":"Cha","year":"2013","journal-title":"J Ultrasound Med"},{"key":"10.1016\/j.phro.2022.11.001_b0125","article-title":"Comparison of MRI-based and conventional measurements for proton beam therapy of uveal melanoma","author":"Jaarsma-Coes","year":"2022","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.phro.2022.11.001_b0130","doi-asserted-by":"crossref","first-page":"100697","DOI":"10.1016\/j.adro.2021.100697","article-title":"An automatic framework to create patient-specific eye models from 3D magnetic resonance images for treatment selection in patients with uveal melanoma","volume":"6","author":"Hassan","year":"2021","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.phro.2022.11.001_b0135","doi-asserted-by":"crossref","unstructured":"Jaarsma-Coes M, Klaassen L, Verbist BM, Vu THK, Klaver YLB, et al. Inter-Observer variability in MR-based target volume delineation of uveal melanoma. submitted. 2022.","DOI":"10.1016\/S0167-8140(22)02313-1"},{"key":"10.1016\/j.phro.2022.11.001_b0140","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.radonc.2021.11.036","article-title":"Variability of gross tumour volume delineation: MRI and CT based tumour and lymph node delineation for lung radiotherapy","volume":"167","author":"Kumar","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2022.11.001_b0145","doi-asserted-by":"crossref","first-page":"10100","DOI":"10.18632\/oncotarget.24071","article-title":"Appropriate magnetic resonance imaging techniques for gross tumor volume delineation in external beam radiation therapy of locally advanced cervical cancer","volume":"9","author":"Song","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.phro.2022.11.001_b0150","series-title":"AJCC cancer staging manual","first-page":"p. 805:17","article-title":"Uveal melanoma","author":"Kivel\u00e4","year":"2016"},{"key":"10.1016\/j.phro.2022.11.001_b0155","doi-asserted-by":"crossref","unstructured":"Kitslaar Pieter H, Staring M, Lelieveldt BPF, van der Geest RJ. Segmentation of branching vascular structures using adaptive subdivision surface fitting. Proceedings Volume 9413, Medical Imaging 2015: Image Processing; 94133Z 2015. https:\/\/doi.org\/10.1117\/12.2082222.","DOI":"10.1117\/12.2082222"},{"key":"10.1016\/j.phro.2022.11.001_b0160","doi-asserted-by":"crossref","unstructured":"Collaborative Ocular Melanoma Study G. Comparison of clinical, echographic, and histopathological measurements from eyes with medium-sized choroidal melanoma in the collaborative ocular melanoma study: COMS report no. 21. Arch Ophthalmol 2003;121:1163-71. https:\/\/doi.org\/10.1001\/archopht.121.8.1163.","DOI":"10.1001\/archopht.121.8.1163"},{"key":"10.1016\/j.phro.2022.11.001_b0165","unstructured":"Varian Medical Systems. Planning Reference Guide for Eclipse Ocular Proton Planning. 2007; 1\u2013286."},{"key":"10.1016\/j.phro.2022.11.001_b0170","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.radonc.2020.08.023","article-title":"Potential and pitfalls of 1.5T MRI imaging for target volume definition in ocular proton therapy","volume":"154","author":"Via","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2022.11.001_b0175","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1002\/nbm.3041","article-title":"High-resolution MRI of uveal melanoma using a microcoil phased array at 7 T","volume":"26","author":"Beenakker","year":"2013","journal-title":"NMR Biomed"},{"key":"10.1016\/j.phro.2022.11.001_b0180","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/jmri.27939","article-title":"A comparison of 3 T and 7 T MRI for the clinical evaluation of uveal melanoma","volume":"55","author":"Tang","year":"2022","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.phro.2022.11.001_b0185","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/S0161-6420(84)34088-X","article-title":"Growth rates and doubling times of posterior uveal melanomas","volume":"91","author":"Augsburger","year":"1984","journal-title":"Ophthalmology"},{"key":"10.1016\/j.phro.2022.11.001_b0190","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1001\/archopht.1997.01100160184007","article-title":"Uveal melanoma. Growth rate and prognosis","volume":"115","author":"Char","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.phro.2022.11.001_b0195","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s00066-005-1342-6","article-title":"Does the imaging method have an influence on the measured tumor height in ruthenium plaque therapy of uveal melanoma?","volume":"181","author":"Schueller","year":"2005","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.phro.2022.11.001_b0200","doi-asserted-by":"crossref","unstructured":"Beenakker JM, Rasch CRN. Letter to the Editor of Radiotherapy and Oncology regarding the paper titled \u201cMRI and FUNDUS image fusion for improved ocular biometry in Ocular Proton Therapy\u201d by Via et al. Radiother Oncol 2022. https:\/\/doi.org\/10.1016\/j.radonc.2022.08.018.","DOI":"10.1016\/j.radonc.2022.08.018"},{"key":"10.1016\/j.phro.2022.11.001_b0205","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.radonc.2022.06.021","article-title":"MRI and FUNDUS image fusion for improved ocular biometry in Ocular Proton Therapy","volume":"174","author":"Via","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2022.11.001_b0210","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.radonc.2017.01.010","article-title":"Treatment plan optimization and robustness of (106)Ru eye plaque brachytherapy using a novel software tool","volume":"123","author":"Heilemann","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2022.11.001_b0215","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.brachy.2020.01.001","article-title":"Influence of tumor shape and location in eye plaque brachytherapy dosimetry","volume":"19","author":"Studenski","year":"2020","journal-title":"Brachytherapy"},{"key":"10.1016\/j.phro.2022.11.001_b0220","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.brachy.2017.06.014","article-title":"Incorporating patient-specific CT-based ophthalmic anatomy in modeling iodine-125 eye plaque brachytherapy dose distributions","volume":"16","author":"Tien","year":"2017","journal-title":"Brachytherapy"},{"key":"10.1016\/j.phro.2022.11.001_b0225","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1118\/1.2068927","article-title":"3D MRI-based tumor delineation of ocular melanoma and its comparison with conventional techniques","volume":"32","author":"Daftari","year":"2005","journal-title":"Med Phys"},{"key":"10.1016\/j.phro.2022.11.001_b0230","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.2147\/OPTH.S238405","article-title":"The economic value of MR-imaging for uveal melanoma","volume":"14","author":"Grech Fonk","year":"2020","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.phro.2022.11.001_b0235","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.sjopt.2013.06.014","article-title":"Proton beam radiotherapy of uveal melanoma","volume":"27","author":"Damato","year":"2013","journal-title":"Saudi J Ophthalmol"},{"key":"10.1016\/j.phro.2022.11.001_b0240","doi-asserted-by":"crossref","first-page":"e0242966","DOI":"10.1371\/journal.pone.0242966","article-title":"Visual outcomes of proton beam therapy for choroidal melanoma at a single institute in the Republic of Korea","volume":"15","author":"Jung","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.phro.2022.11.001_b0245","first-page":"13","article-title":"Clinical outcomes after international referral of uveal melanoma patients for proton therapy","author":"Marinkovic","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.phro.2022.11.001_b0250","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/mp.14665","article-title":"Three-dimensional MRI-based treatment planning approach for non-invasive ocular proton therapy","volume":"48","author":"Fleury","year":"2021","journal-title":"Med Phys"},{"key":"10.1016\/j.phro.2022.11.001_b0255","first-page":"59","article-title":"OCTOPUS: a planning tool for proton therapy of eye tumours","volume":"17","author":"Pfeiffer","year":"2001","journal-title":"Phys Med"},{"key":"10.1016\/j.phro.2022.11.001_b0260","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1002\/mp.15573","article-title":"Technical note: Impact of beam properties for uveal melanoma proton therapy-An in silico planning study","volume":"49","author":"Wulff","year":"2022","journal-title":"Med Phys"}],"container-title":["Physics and Imaging in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405631622000914?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405631622000914?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:14:50Z","timestamp":1762503290000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405631622000914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":52,"alternative-id":["S2405631622000914"],"URL":"https:\/\/doi.org\/10.1016\/j.phro.2022.11.001","relation":{},"ISSN":["2405-6316"],"issn-type":[{"value":"2405-6316","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Automatic Three-Dimensional Magnetic Resonance-based measurements of tumour prominence and basal diameter for treatment planning of uveal melanoma","name":"articletitle","label":"Article Title"},{"value":"Physics and Imaging in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phro.2022.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V. on behalf of European Society of Radiotherapy & Oncology.","name":"copyright","label":"Copyright"}]}}